#1 out of 1
health1d ago
Key facts: Eli Lilly co-develops ELUNATE®; Endowment sells 162,693 shares
- Eli Lilly co-develops ELUNATE with HUTCHMED in China and will feature the drug at major 2025 conferences.
- Lilly Endowment Inc. sold 162,693 Eli Lilly shares in two transactions, reducing its stake to 92,196,978 shares.
Vote 0
